March 3, 2020

ASKA Biotech announces management board changes

Hennigsdorf, 03.03.2020 – ASKA Biotech announced new members of it’s management. The current owner and CEO Siegmund Karasch will be supported from now on by Anke Holzinger and Alexandra Rindermann.

Since October 2019 all three members built up together the ASKA business to provide customers independent high-quality services for development and production of monoclonal antibodies and recombinant proteins.

Siegmund Karasch knows both since over 8 years and worked with them already in his former business. He said, “I´m happy to make up the management board with these two ladies. I know them well from my last company and I´m confident, that we will complement each other to push ASKA Biotech forward.”

Anke Holzinger will be in charge for Business Development and Marketing department at ASKA Biotech and accelerates the digital transformation of the processes. “I´m looking forward to boost the services and business with the team. Next to further protein analysis methods we will implement a new platform to provide our customers a new ordering journey.”

Alexandra Rindermann represents the Quality Management and Quality Control department. “My focus will be reinforcement of our quality management system according DIN EN ISO 9001:2015 and the system set up according ISO 13485. Next to our current services, we will extend the service portfolio for protein analysis and characterization.”


New Management at ASKA Biotech

Anke Holzinger, Siegmund Karasch, Alexandra Rindermann